Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More
VNDA and JAZZ are in the spotlight following regulatory and pipeline updates, respectively.
| Ticker |
Sentiment |
Impact |
|
EXEL
|
Somewhat Bullish
|
43 %
|
|
NVAX
|
Neutral
|
12 %
|
|
JAZZ
|
Neutral
|
8 %
|
|
VNDA
|
Neutral
|
16 %
|
